Clinical characteristics and laboratory testing of patients with suspected HIT: A survey on current practice in 11 university hospitals in France

Thrombosis Research

Volumn 125, Issue 6, 2010, Pages

  Bidet, Audrey ^a   Tardy Poncet, Brigitte ^b   Desprez, Dominique ^c   de Maistre, Emmanuel ^d   Presles, Emilie ^b   Lecompte, Thomas ^e   Lavenu Bombled, Cecile ^f   Huisse, Marie Genevieve ^g   Wolf, Martine ^h   Morange, Pierre ⁱ   Racadot, Evelyne ^j   Mouton, Christine ^a   GruneBaum, Lelia ^c   Pouplard, Claire ^k   Tardy, Bernard ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^j UNIVERSITY HOSPITAL OF BESANÇON   (France)

^k UNIVERSITY HOSPITAL OF TOURS   (France)

more..

Author keywords

Clinical score; Current practice; Heparin induced thrombocytopenia; Thrombocytopenia; Thrombosis

Indexed keywords

DANAPAROID; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; CHONDROITIN SULFATE; DERMATAN SULFATE; HEPARAN SULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FRANCE; HEALTH SURVEY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; CHEMICALLY INDUCED; COMPLICATION; DIAGNOSTIC PROCEDURE; IMMUNOLOGY; INFORMATION PROCESSING; MEDICAL RECORD; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; THROMBOCYTOPENIA; THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHONDROITIN SULFATES; DATA COLLECTION; DERMATAN SULFATE; FEMALE; FRANCE; HEPARIN; HEPARITIN SULFATE; HOSPITALS, UNIVERSITY; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MEDICAL RECORDS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; THROMBOCYTOPENIA; THROMBOSIS; YOUNG ADULT; CLINICAL LABORATORY TECHNIQUES;

EID: 77952672716     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.02.003     Document Type: Article

References (19)

1. Amiral J., Bridey F., Dreyfus M., Vissac A., and Fressinaud E. Wolf, M. Meyer, D. Platelet factor 4 complexed to heparin is the target of antibodies generated in heparin induced thrombocytopenia. Thromb Haemost 68 (1992) 95-96
2. Warkentin T.E. Heparin induced thrombocytopenia: pathogenesis and management. Brit J Haematol 121 (2003) 535-555
3. Amiral J., Wolf M., Fischer A., Boyer-Neumann C., Vissac A., and Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin induced thrombocytopenia. Brit J Haematol 92 (1996) 954-959
4. Tardy-Poncet B., Piot M., Rancon F., Tardy B., Reynaud J., Campos L., et al. Confirmation of the pathogenic role of Ig M and Ig A anti heparin- PF4 antibodies in patients with heparin-induced thrombocytopenia. J Thromb Haemost 3 S1 (2005) 310
5. Greinacher A., Juhl D., Strobel U., Wessel A., Lubenow N., Selleng K., et al. Heparin induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/ heparin antibodies of the IgG, IgM and IgA classes. J Thromb Haemost 5 (2007) 1666-1673
6. Amiral J., Marfaing-Koka A., Wolf M., Alessi M.C., Tardy B., Boyer-Neumann C., et al. Presence of antibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin associated thrombocytopenia. Blood 88 (1996) 410-416
7. Martel N., Lee J., and Wells P.S. Risk for heparin-induced thrombocytopenia with unfractionated heparin and low-molecular-weight heparins. Blood 105 (2005) 2710-2715
8. Lee D.H., and Warkentin T.E. Frequency of heparin induced thrombocytopenia. In: Warkentin T.E., and Greinacher A. (Eds). heparin induced thrombocytopenia. 4th ed. (2007), Informa Healthcare USA, New York, NY 67-116
9. Warkentin T.E., Greinacher A., Koster A., and Linoff A.M. Treatment and prevention of heparin induced thrombocytopenia. Chest 133 (2008) 340S-380S
10. Warkentin T.E., and Kelton J.G. Delayed-onset heparin induced thrombocytopenia and thrombosis. Ann Intern Med 135 (2001) 502-506
11. Lillo-Le Louët A., Boutouyrie P., Alhenc-Gelas M., Le Beller C., Gauthier I., Aiach M., et al. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost 2 (2004) 1882-1888
12. Pouplard C., May M.A., Regina S., Marchand M., Fusciardi J., and Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Brit J Haematol 128 (2005) 837-841
13. Price E.A., Hayward C.P.M., Moffat J.C., Warkentin T.E., and Zehnder J.L. Laboratory testing for heparin induced thrombocytopenia is inconsistent in North America: A survey of North America specialized coagulation laboratories. Thromb Haemost 98 (2007) 1357-1361
14. Lo G.K., Juhl D., Warkentin T.E., Sigouin C.S., Eichler P., and Greinacher A. Evaluation of pretest clinical score (4T's) for the diagnosis of heparin induced thrombocytopenia in two clinical settings. J Thromb Haemost 4 (2006) 759-765
15. Fohlen-Walter A., De Maistre E., Mulot A., Marchand-Arvier M., and Lecompte T. Does negative heparin-platelet factor 4 enzyme-linked immunosorbent assay effectively exclude heparin-induced thrombocytopenia?. Thromb Haemost 1 (2003) 1844-1845
16. Greinacher A., Juhl D., Strobel U., Wessel A., Lubenow N., Selleng K., et al. Heparin induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/ heparin antibodies of the IgG, IgM and IgA classes. Thromb Haemost 5 (2007) 1666-1673
17. Warkentin T.E., Sheppard J.O., Moore J.C., Moore K.M., Sigouin C.S., and Kelton J.G. Laboratory testing for antibodies that cause heparin induced thrombocytopenia: How much class do we need?. J Lab Clin Med 146 (2005) 341-346
18. Elalamy I., Tardy-Poncet B., Mulot A., de Maistre E., Pouplard C., Nguyen P., et al. Risk factors for unfavourable clinical outcome in patients with documented heparin induced thrombocytopenia. Thromb Res 124 (2009) 554-559
19. Conférence d'experts. Heparin induced thrombocytopenia. Ann Fr Anesth Réanim 22 (2003) 150-159